Identification of new pyridinium ionic liquids tagged with Schiff bases: Design, synthesis, in silico ADMET predictions and biological evaluations

2018 ◽  
Vol 264 ◽  
pp. 367-374 ◽  
Author(s):  
Nadjet Rezki ◽  
Salsabeel A. Al-Sodies ◽  
Mouslim Messali ◽  
Sanaa K. Bardaweel ◽  
Pramod K. Sahu ◽  
...  
2021 ◽  
Vol 108 ◽  
pp. 104669
Author(s):  
Asmaa M Sayed ◽  
Fatma A. Taher ◽  
Mohammad R.K. Abdel-Samad ◽  
Mohamed S.A. El-Gaby ◽  
Khaled El‐Adl ◽  
...  

2020 ◽  
Vol 32 (8) ◽  
pp. 1972-1980
Author(s):  
Anas R. Al Johani ◽  
Saud M. Almutairi ◽  
Wael S. El-Sayed ◽  
Pramod K. Sahu ◽  
Praveen K. Sahu ◽  
...  

A series of sixteen new ionic liquids (ILs) bearing imidazolium moiety were designed and synthesized under sustainable and green conditions which were confirmed by analytical and spectral techniques using 1H- & 13C-NMR, FT-IR, mass and elemental analysis. A panel of clinically isolated strains was used for in vitro inhibitory antimicrobial activities screening of synthesized ionic liquids. The results of antimicrobial assay showed that some of synthesized ionic liquids showed moderate to good activity. Among these ILs, ionic liquids 3, 4 and 5 (bearing alkyl chain with a phenyl group) significantly inhibited cell growth of strains. In this regard, these ionic liquids considered as promising antibacterial agents when compared with standard antibiotics. By encouraging in vitro antimicrobial screening, in silico ADMET evaluation has been performed and found excellent pharmacokinetic, bioavailability and toxicity profiles. Synthesized ionic liquids has found to be safe and non-toxic according to calculated in vivo computed LD50 values (2.49-2.80 mg/kg) for rat acute toxicity.


2019 ◽  
Vol 352 (5) ◽  
pp. 1800387 ◽  
Author(s):  
Abdel‐Ghany A. El‐Helby ◽  
Rezk R. A. Ayyad ◽  
Mohamed F. Zayed ◽  
Hamada S. Abulkhair ◽  
Hazem Elkady ◽  
...  

2021 ◽  
Author(s):  
Khaled El-Adl ◽  
Abdel-Ghany A. El-Helby ◽  
Helmy Sakr ◽  
Alaa Elwan

In view of their DNA intercalation activities as anticancer agents, 17 novel [1,2,4]triazolo[4,3-a]quinoxaline derivatives have been designed, synthesized and evaluated against HepG2, HCT-116 and MCF-7 cells.


2018 ◽  
Vol 265 ◽  
pp. 428-441 ◽  
Author(s):  
Nadjet Rezki ◽  
Mouslim Messali ◽  
Salsabeel A. Al-Sodies ◽  
Arshi Naqvi ◽  
Sanaa K. Bardaweel ◽  
...  

Molecules ◽  
2019 ◽  
Vol 24 (17) ◽  
pp. 3130 ◽  
Author(s):  
Ashraf Hassan ◽  
Ahmed Askar ◽  
Eman Nossier ◽  
Ahmed Naglah ◽  
Gaber Moustafa ◽  
...  

A series of Schiff bases 14–25 were designed and synthesized for evaluation of their antibacterial properties against multi-drug resistant bacteria (MDRB). The antibacterial activities of Schiff bases 14–25 showed that most of the synthesized compounds displayed a significant antibacterial activity. Assessment of in silico ADMET properties (absorption, distribution, metabolism, excretion and toxicity) of Schiff bases illustrates that all derivatives showed agreement to the Lipinski’s rule of five. Further enzymatic assay aided by molecular docking study demonstrated that compound 18 is a potent inhibitor of staphylococcus aureus DNA gyrase and dihydrofolate reductase kinases. This study could be valuable in the discovery of new potent antimicrobial agents.


Sign in / Sign up

Export Citation Format

Share Document